Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial.

Bhanu GuptaKok-Seng CheeLi-Qi NeoCharmaine TangJayaraman HariramGeoffrey Chern-Yee TanSwapna VermaSutapa BasuDeva-Priya AppanChan-Chun TingEdimansyah AbdinJimmy Lee

Published in: Therapeutic advances in psychopharmacology (2021)

Clinicaltrials.gov identifier: NCT02949752.

Keyphrases

open label
phase iii
phase ii
study protocol
clinical trial
placebo controlled
body mass index
phase ii study
weight loss
physical activity
randomized controlled trial
weight gain
double blind